Empagliflozin is an FDA-approved SGLT2 inhibitor marketed under the brand name Jardiance

Drug Policy, Pricing & Approval

Drug pricing and affordability, FDA drug approvals, clinical trial design, drug shortages, insurer coverage, pharmaceutical regulation, and medication access.

1 debate·7,839 claims·655 news stories

Opening sign-in…